Anatara Lifesciences Ltd (ANR)

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
David Brookes Director
Transaction date
Purchase
Price
167.37
Quantity 33,828
Value A$955,236
John Michailidis Director
Transaction date
Purchase
Price
147.11
Quantity 48,424
Value A$3,512,427
John Michailidis Director
Transaction date
Purchase
Price
53.67
Quantity 60,961
Value A$2,942,272
David Brookes Director
Transaction date
Purchase
Price
0.03
Quantity 656,476
Value A$19,046
Jane Ryan Director
Transaction date
Purchase
Price
0.03
Quantity 142,980
Value A$5,000
David Brookes Director
Transaction date
Purchase
Price
0.02
Quantity 2,571,431
Value A$60,000
David Brookes Director
Transaction date
Purchase
Price
0.03
Quantity 150,000
Value A$5,250
Sue MacLeman Director
Transaction date
Purchase
Price
0.16
Quantity 32,259
Value A$5,127
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-12-13 2023-12-11 B Purchase David Brookes Director
33,828
167.37
A$955,236
33,828 167.37 A$955,236
2023-12-12 2023-12-11 B Purchase John Michailidis Director
48,424
147.11
A$3,512,427
48,424 147.11 A$3,512,427
2023-12-11 2023-12-08 B Purchase John Michailidis Director
60,961
53.67
A$2,942,272
60,961 53.67 A$2,942,272
2023-12-11 2023-12-08 B Purchase David Brookes Director
656,476
0.03
A$19,046
656,476 0.03 A$19,046
2022-12-20 2022-12-19 B Purchase Jane Ryan Director
142,980
0.03
A$5,000
142,980 0.03 A$5,000
2022-12-20 2022-12-19 B Purchase David Brookes Director
2,571,431
0.02
A$60,000
2,571,431 0.02 A$60,000
2022-11-30 2022-11-28 B Purchase David Brookes Director
150,000
0.03
A$5,250
150,000 0.03 A$5,250
2021-09-13 2021-09-08 B Purchase Sue MacLeman Director
32,259
0.16
A$5,127
32,259 0.16 A$5,127